Home › Stocks › CERE › All Fund Holders
CERE — CEREVEL THERAPEUTICS HLDNG I · All Fund Holders
Funds holding (latest): 44 · Reported value held: $1.30B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q2 2024 | 7.15M | $292.54M | 0.01% | Reduce |
| Fidelity International (FIL) history | Q2 2024 | 3.25M | $132.97M | 0.13% | Hold |
| Millennium Management history | Q2 2024 | 2.96M | $121.07M | 0.06% | Add |
| Norges Bank Investment Management history | Q2 2024 | 2.34M | $95.51M | 0.01% | Add |
| Soros Fund Management history | Q2 2024 | 2.15M | $87.98M | 1.94% | Add |
| Marshall Wace history | Q2 2024 | 1.87M | $76.44M | 0.10% | Add |
| Geode Capital Management history | Q2 2024 | 1.47M | $60.11M | 0.01% | Reduce |
| Citigroup Inc history | Q2 2024 | 1.28M | $52.51M | 0.04% | Reduce |
| Citadel Advisors history | Q2 2024 | 1.27M | $51.93M | 0.01% | Add |
| Farallon Capital Management history | Q2 2024 | 1.19M | $48.66M | 0.23% | New |
| Goldman Sachs Group history | Q2 2024 | 1.02M | $41.75M | 0.01% | Hold |
| JPMorgan Chase & Co history | Q2 2024 | 697.51K | $28.52M | 0.01% | Add |
| Northern Trust Corp history | Q2 2024 | 645.28K | $26.39M | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2024 | 596.41K | $24.39M | 0.04% | Reduce |
| Alkeon Capital Management history | Q2 2023 | 699.70K | $22.24M | 0.04% | Reduce |
| Charles Schwab Investment Management history | Q2 2024 | 522.93K | $21.38M | 0.00% | Reduce |
| UBS Group AG history | Q2 2024 | 407.36K | $16.66M | 0.00% | Add |
| Renaissance Technologies history | Q2 2024 | 361.40K | $14.78M | 0.03% | Reduce |
| Bank of America Corp history | Q2 2024 | 338.45K | $13.84M | 0.00% | Add |
| Morgan Stanley history | Q2 2024 | 330.73K | $13.52M | 0.00% | Reduce |
| Janus Henderson Group history | Q2 2024 | 293.38K | $12.00M | 0.01% | Add |
| Davidson Kempner Capital Management history | Q2 2024 | 260.40K | $10.65M | 0.24% | New |
| BNY Mellon history | Q2 2024 | 249.36K | $10.20M | 0.00% | Reduce |
| CPP Investments history | Q2 2024 | 113.50K | $4.64M | 0.01% | Reduce |
| Legal & General Investment Management America history | Q2 2024 | 79.88K | $3.27M | 0.00% | Add |
| Invesco Ltd history | Q2 2024 | 57.34K | $2.34M | 0.00% | Add |
| Casdin Capital history | Q3 2022 | 80.00K | $2.26M | 0.15% | New |
| D. E. Shaw & Co history | Q2 2024 | 44.44K | $1.82M | 0.00% | Reduce |
| Moore Capital Management history | Q2 2024 | 42.60K | $1.74M | 0.03% | New |
| Wellington Management Group history | Q4 2023 | 35.58K | $1.51M | 0.00% | Reduce |
| Point72 Asset Management history | Q2 2024 | 35.00K | $1.43M | 0.00% | New |
| Two Sigma Investments history | Q1 2024 | 19.70K | $832.72K | 0.00% | Hold |
| AQR Capital Management history | Q2 2024 | 19.82K | $810.28K | 0.00% | Hold |
| Fidelity Management & Research (FMR) history | Q2 2024 | 14.88K | $608.46K | 0.00% | Reduce |
| Principal Global Investors history | Q2 2024 | 12.15K | $496.65K | 0.00% | Reduce |
| Manulife Financial history | Q2 2024 | 7.45K | $304.63K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2024 | 5.92K | $242.27K | 0.00% | Reduce |
| Prudential Financial history | Q1 2024 | 5.10K | $215.53K | 0.00% | Hold |
| Amundi US history | Q3 2022 | 7.05K | $210.00K | 0.00% | Hold |
| Franklin Resources history | Q4 2022 | 6.61K | $208.57K | 0.00% | New |
| Wells Fargo & Co history | Q2 2024 | 1.42K | $57.86K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2024 | 53.40K | $2.18K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2024 | 16 | $654 | 0.00% | Add |
| Lazard Asset Management history | Q2 2023 | 7.34K | $233 | 0.00% | Reduce |